BioMedical SIG #4

BioMedical SIG #4

Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success.

Book Your Place

This event has now expired

Fourth webinar in the series: From research and innovation to development: how to plan and execute translational projects in life sciences, this edition looks more closely at IP protection strategies for translational research.

It focuses on intellectual property (IP) and spin-out strategies in the human healthcare sector. A well-designed IP strategy, tailored to the type of innovation, is crucial for the long-term success of university spin-outs.

Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements. They’ll share insights on the essential components of an IP strategy for the healthcare sector and discuss how these components vary based on the type of innovation—whether in biotech, pharma, or digital health—and the intended business model.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

Great networking, new knowledge and inspiration!

Jonas Rimbäck

University of Gothenburg, Sweden

testimonial

One very long and hard day, but very useful for my work in TTO.

Petr Kubečka

Palacký University Olomouc, Czech Republic

testimonial

ASTP Conference offers great networking and learning opportunities;  a chance to share knowledge with colleagues from various areas of expertise.

Bruno Woeran

Merinova OY - TII President, Finland

testimonial

Good opportunity to discuss common issues with fellow professionals and to get updates about the community.

Giuseppe Visimberga

Leiden University, Netherlands

testimonial

A must-do for any staff involved in technology transfer and start-up creation.

Frederic Ratel

Institute of Chemical Research of Catalonia, Spain